APLT•benzinga•
Reported Sunday, Applied Therapeutics Reports 24-Month Data From INSPIRE Trial Showing Govorestat Slows Disease Progression In CMT-SORD, Reinforces Plans For 2025 NDA
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 19, 2025 by benzinga